VANGUARD GROUP INC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 39 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$751,489
-31.5%
6,483,9450.0%0.00%
Q4 2022$1,097,732
-14.6%
6,483,945
+0.1%
0.00%
Q3 2022$1,286,000
-60.4%
6,480,6880.0%0.00%
Q2 2022$3,247,000
-12.3%
6,480,6880.0%0.00%
Q1 2022$3,701,000
-6.2%
6,480,688
-0.6%
0.00%
Q4 2021$3,944,000
-37.5%
6,518,856
+0.1%
0.00%
Q3 2021$6,315,000
-9.1%
6,509,454
+3.1%
0.00%
Q2 2021$6,945,000
+28.9%
6,313,841
+10.2%
0.00%
Q1 2021$5,387,000
+438.2%
5,731,522
+177.7%
0.00%
Q4 2020$1,001,000
-34.6%
2,063,723
+5.6%
0.00%
Q3 2020$1,530,000
+50.1%
1,953,423
+2.8%
0.00%
Q2 2020$1,019,000
+51.4%
1,899,551
+0.7%
0.00%
Q1 2020$673,000
-49.1%
1,886,2370.0%0.00%
Q4 2019$1,322,000
-2.7%
1,886,237
-2.2%
0.00%
Q3 2019$1,359,000
-41.6%
1,929,094
+7.7%
0.00%
Q2 2019$2,328,000
-35.6%
1,791,266
+4.5%
0.00%
Q1 2019$3,616,000
+51.1%
1,713,768
+61.1%
0.00%
Q4 2018$2,393,000
-58.2%
1,063,512
-35.1%
0.00%
Q3 2018$5,731,000
+38.9%
1,637,513
+27.1%
0.00%
Q2 2018$4,125,000
-8.0%
1,288,868
+0.6%
0.00%
Q1 2018$4,484,000
-17.7%
1,281,068
+3.5%
0.00%
Q4 2017$5,446,000
-7.9%
1,237,796
+9.3%
0.00%
Q3 2017$5,914,000
+20.6%
1,132,029
+20.1%
0.00%
Q2 2017$4,903,000
+49.5%
942,940
+22.2%
0.00%
Q1 2017$3,280,000
+52.3%
771,773
+12.9%
0.00%
Q4 2016$2,154,000
+14.6%
683,799
+24.7%
0.00%
Q3 2016$1,880,000
+100.0%
548,314
+63.3%
0.00%
Q2 2016$940,000
-44.4%
335,814
+21.8%
0.00%
Q1 2016$1,690,000
+19.4%
275,617
+5.2%
0.00%
Q4 2015$1,415,000
-99.3%
262,085
-94.9%
0.00%
-100.0%
Q3 2015$189,665,000
+17860.7%
5,185,244
+1962.7%
0.01%
Q2 2015$1,056,000
+13.4%
251,382
+6.4%
0.00%
Q1 2015$931,000
+151.6%
236,240
+294.0%
0.00%
Q4 2014$370,000
+262.7%
59,958
+175.2%
0.00%
Q3 2014$102,00021,7880.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders